Effects of Recurrent Application of Liquid-PRF on Hard and Soft Tissues
Liquid-PRF
The Effect of Recurrent Application of Liquid Platelet-rich Fibrin in the Extraction Socket on the Hard and Soft Tissues. A Randomised Controlled Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
Procedure: Tooth is extracted, then A-PRF+ is placed inside the socket. After that the ridge dimensions is asses clinically at the baseline) in addition to clinical assessment of the gingival biotype at the baseline. Then patients will be divided into 2 groups: Group 1: 50% of patients will have recurrent Liquid-PRF injections inside the extraction socket every 2 weeks (A-PRF+, followed by recurrent Liquid-PRF) Group 2: 50% of patients without recurrent (just A-PRF+) After 3 months from extraction: both groups will be assessed clinically (gingival biotype) \& (Ridge dimensions) in order to assess the role of recurrent application of Liquid-PRF on these parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2022
CompletedFirst Submitted
Initial submission to the registry
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
August 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2022
CompletedNovember 9, 2022
November 1, 2022
2 months
August 1, 2022
November 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Ridge dimensions
assessment of ridge dimensions 3 months after intervention for both groups. At the baseline it was assessed clinically. After 3 months, the flap was released and the ridge width and height were assessed clinically.
3 months
Gingival biotype
assessment of gingival biotype 3 months after intervention according to gingival thickness (using periodontal probe: if \<1 mm = Thin, while if \>1 =Thick).
3 months
Study Arms (2)
Advanced platelet-rich fibrin plus + Liquid platelet-rich fibrin
EXPERIMENTALA-PRF plus + Liquid-PRF are prepared from the patient's blood.
Advanced platelet-rich fibrin plus alone
EXPERIMENTALA-PRF+ is prepared from the patient's blood.
Interventions
Liquid platelet-rich fibrin is prepared from the patient's blood and injected into the extraction socket every two weeks (up to 3 months = Just 4 times of application)
A-PRF+ is placed into the extraction socket immediately after tooth extraction
Eligibility Criteria
You may qualify if:
- Men and women over 18 years of age
- Indication of a simple extraction (Non-molar tooth)
- Delivery of signed informed consent
- Need delayed implant placement in the place of extraction
You may not qualify if:
- Need for multiple extractions
- Presence of severe swelling prior to surgery in the extraction area
- Regular treatment with non-steroidal anti-inflammatory drugs (NSAIDs) or other anti-inflammatory drugs
- Presence of hematologic disease
- Previous radiation, chemotherapy, or immunosuppressive treatments
- Uncontrolled diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cezar Lahham
Bethlehem, 00000, Palestinian Territories
Related Publications (1)
Lahham C, Ta'a MA, Lahham E, Michael S, Zarif W. The effect of recurrent application of concentrated platelet-rich fibrin inside the extraction socket on the hard and soft tissues. a randomized controlled trial. BMC Oral Health. 2023 Sep 19;23(1):677. doi: 10.1186/s12903-023-03400-5.
PMID: 37726689DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 1, 2022
First Posted
August 8, 2022
Study Start
June 15, 2022
Primary Completion
August 15, 2022
Study Completion
October 18, 2022
Last Updated
November 9, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share